Healthcare - Biotechnology - NASDAQ - US
$ 4.265
-10.6 %
$ 111 M
Market Cap
-0.84
P/E
INCOME STATEMENT
832 K
REVENUE
-135 M
OPERATING INCOME
-135 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Inovio Pharmaceuticals, Inc.
| Revenue | 832 K |
| Cost Of Revenue | 3.5 M |
| Gross Profit | -2.67 M |
| Operating Expenses | 133 M |
| Operating Income | -135 M |
| Other Expenses | -109 K |
| Net Income | -135 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Mar-2000 | Mar-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||
| Revenue | 0.8 | 10.3 | 1.8 | 7.4 | 4.1 | 30.5 | 42.2 | 35.4 | 40.6 | 10.5 | 13.5 | 4.1 | 9.8 | 6.1 | 9.1 | 2.1 | 4.8 | 3.5 | 5.5 | 1.2 | 80.5 K | 0.2 | 4.5 | 5.1 | 8.3 |
| GROSS PROFIT | |||||||||||||||||||||||||
| Cost Of Revenue | 3.5 | 5.5 | 4.7 | 94.2 | 88.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.2 | 0 | 0 | 0 | 1.9 | 1.5 | 1.2 |
| Gross Profit | (2.7) | 4.8 | (3.0) | (86.8) | (83.9) | 30.5 | 42.2 | 35.4 | 40.6 | 10.5 | 13.5 | 4.1 | 9.8 | 6.1 | 9.1 | 2.1 | 4.8 | 3.2 | 5.3 | 1.2 | 80.5 K | 0.2 | 2.5 | 3.6 | 7.1 |
| OPERATING INCOME | |||||||||||||||||||||||||
| Operating Expenses | 132.6 | 277.8 | 303.0 | 131.5 | 115.2 | 124.6 | 126.9 | 112.6 | 75.9 | 50.0 | 35.0 | 28.8 | 32.0 | 25.4 | 23.1 | 15.8 | 20.7 | 16.8 | 17.6 | 12.7 | 6.7 | 6.1 | 7.1 | 13.2 | 14.0 |
| Selling, General and Administrative Expenses | 47.6 | 90.2 | 53.8 | 37.2 | 27.2 | 29.3 | 28.3 | 23.9 | 18.1 | 15.9 | 13.6 | 10.8 | 12.0 | 12.1 | 13.7 | 10.0 | 11.1 | 8.1 | 6.0 | 6.1 | 4.6 | 3.7 | 6.6 | 5.6 | 5.5 |
| Research and Development Expenses | 88.5 | 187.7 | 249.2 | 94.2 | 88.0 | 95.3 | 98.6 | 88.7 | 57.8 | 34.1 | 21.4 | 18.0 | 20.0 | 13.3 | 9.4 | 5.8 | 9.6 | 8.5 | 11.5 | 6.5 | 2.1 | 2.5 | 0.5 | 7.0 | 8.1 |
| Operating Income | (135.2) | (267.6) | (301.2) | (124.1) | (111.1) | (94.1) | (83.6) | (76.2) | (34.3) | (39.5) | (19.5) | (23.5) | (21.6) | (19.2) | (14.0) | (13.7) | (15.9) | (13.3) | (15.5) | (11.5) | (6.6) | (5.9) | (5.6) | (9.5) | (6.9) |
| PRE-TAX INCOME | |||||||||||||||||||||||||
| Interest Income Expense | 1.2 | 1.3 | 1.9 | 8.7 | 7.9 | 0.3 | 4.6 | 0.1 | 0 | 0 | 88.2 | 0 | 34.3 K | 0 | 10.5 | 0 | 0 | 0 | 3.3 | 0 | 20.5 K | 5.44 K | 20.4 K | 24.3 K | 24.3 K |
| Total Other Income | 0.1 | (10.1) | (2.0) | (38.8) | (9.7) | (0.7) | (4.6) | 2.5 | 3.1 | 3.4 | (46.5) | 3.8 | 6.3 | 1.5 | (10.5) | 0.7 | 3.4 | 0.9 | 2.44 K | 0.2 | 6.6 | 26.9 K | (3.3) | (0.6) | 2.9 |
| Pre-Tax Income | (135.1) | (277.7) | (303.2) | (162.9) | (120.8) | (94.8) | (88.2) | (73.7) | (31.2) | (36.1) | (66.1) | (19.7) | (12.9) | (17.7) | (24.5) | (13.6) | (12.5) | (14.5) | (15.5) | 0.66 | 0.43 | (5.9) | (8.9) | (10.1) | (6.6) |
| NET INCOME | |||||||||||||||||||||||||
| Tax Provision | 0 | 10.0 | 2.2 | 52.2 | (0.3) | 2.2 | 1.8 | (4.6) | (2.1) | (3.7) | 88.1 | (8.1) | (16.3) | (4.1) | 11.7 | (0.7) | (8.1) | (0.9) | 6.5 | (0.5) | (2.0) | 56.8 K | 0 | 0.6 | (0.6) |
| Net Income | (135.1) | (287.7) | (305.4) | (215.1) | (120.6) | (97.0) | (88.2) | (73.7) | (29.2) | (36.1) | (66.0) | (19.7) | (15.3) | (17.6) | (24.4) | (13.0) | (11.2) | (12.5) | (15.3) | (11.0) | (4.7) | (6.0) | (8.9) | (9.6) | (6.6) |
| EPS | 6.09 | 14.5 | 17.6 | 16.6 | 14.7 | 1.05 | 1.08 | 1.01 | 0.43 | 0.61 | 1.43 | 0.58 | 0.48 | 0.68 | 1.31 | 1.18 | 1.08 | 1.58 | 3.22 | 2.49 | 1.4 | 2.35 | 5.13 | 6.8 | 5.21 |